E-LIB Suche - Ergebnisse für: Bukofzer, Stan

1

Partial vasopressin 1a receptor agonism reduces portal hype..:

Fernández-Varo, Guillermo ; Jiménez, Wladimiro ; Cable, Edward...
Biomedicine & Pharmacotherapy. 165 (2023) - p. 115116 , 2023

Link: https://doi.org/10.1016/..

2

Selective Partial Agonism of Vasopressin 1a Receptors In Vi..:

Croston, Glenn ; Cable, Edward E. ; Toy, Jeannine...
Journal of Pharmacology and Pharmacotherapeutics. 14 (2023) 1 - p. 54-61 , 2023

Link: https://doi.org/10.1177/..

3

OCE-205, A Novel, Selective Vasopressin Receptor Mixed Agon..:

Bagger, Yu ; Ravis, William R. ; Harris, Geoff.
Clinical Drug Investigation. 43 (2023) 9 - p. 709-717 , 2023

Link: https://doi.org/10.1007/..

4

OCE-205 in rats and non-human primates: Pharmacokinetic and..:

Bukofzer, Stan ; Harris, Geoff ; Cable, Edward E.
Current Research in Pharmacology and Drug Discovery. 5 (2023) - p. 100163 , 2023

Link: https://doi.org/10.1016/..

5

OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pr..:

Bukofzer, Stan ; Harris, Geoffrey ; Song, Susan.
Journal of Experimental Pharmacology. 15 (2023) - p. 279-290 , 2023

Link: https://doi.org/10.2147/..

6

Pharmacokinetics/pharmacodynamics of L‐ornithine phenylacet..:

Safadi, Rifaat ; Rahimi, Robert S. ; Thabut, Dominique...
Clinical and Translational Science. 15 (2022) 6 - p. 1449-1459 , 2022

Link: https://doi.org/10.1111/..

7

Efficacy and Safety of Ornithine Phenylacetate for Treating..:

Rahimi, Robert S. ; Safadi, Rifaat ; Thabut, Dominique...
Clinical Gastroenterology and Hepatology. 19 (2021) 12 - p. 2626-2635.e7 , 2021

Link: https://doi.org/10.1016/..

8

Safety, tolerability, and pharmacokinetics of l‐ornithine p..:

Stravitz, R. Todd ; Gottfried, Michelle ; Durkalski, Valerie...
Hepatology. 67 (2018) 3 - p. 1003-1013 , 2018

Link: https://doi.org/10.1002/..

9

Effect of caffeine on SPECT myocardial perfusion imaging du..:

Tejani, Furqan H. ; Thompson, Randall C. ; Kristy, Rita.
The International Journal of Cardiovascular Imaging. 30 (2014) 5 - p. 979-989 , 2014

Link: https://doi.org/10.1007/..

10

A randomized, double-blind, placebo-controlled study of the..:

Ananthasubramaniam, Karthik ; Weiss, Robert ; McNutt, Bruce...
Journal of Nuclear Cardiology. 19 (2012) 2 - p. 319-329 , 2012

Link: https://doi.org/10.1007/..

11

Finding unrecognized information in overactive bladder clin..:

Zinner, Norman R. ; Ammann, Larry P. ; Haas, Gabriel P....
Neurourology and Urodynamics. 32 (2012) 4 - p. 308-313 , 2012

Link: https://doi.org/10.1002/..

12

A randomized, double-blind, placebo-controlled study assess..:

Prenner, Bruce M. ; Bukofzer, Stan ; Behm, Sarah..
Journal of Nuclear Cardiology. 19 (2012) 4 - p. 681-692 , 2012

Link: https://doi.org/10.1007/..

13

Double–Blind, Crossover Comparison of 3 mg Apomorphine SL w..:

Dula, Eugene ; Bukofzer, Stan ; Perdok, Renee.
European Urology. 39 (2001) 5 - p. 558-564 , 2001

Link: https://doi.org/10.1159/..

14

OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pr..:

Bukofzer, Stan ; Harris, Geoffrey ; Song, Susan.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352125/. , 2023

Link: http://www.ncbi.nlm.nih...

15

OCE-205 in rats and non-human primates: Pharmacokinetic and..:

Bukofzer, Stan ; Harris, Geoff ; Cable, Edward E
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10440361/. , 2023

Link: http://www.ncbi.nlm.nih...